C-reactive protein mediates protection from lipopolysaccharide through interactions with FcγR

Journal of Immunology

Volumn 169, Issue 12, 2002, Pages 7019-7025

  Mold, Carolyn ^b   Rodriguez, Wilfredo ^b   Rodic Polic, Bojana ^b   Du Clos, Terry W ^a,b  

^a VA Medical Center   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; FC RECEPTOR; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; FC GAMMA RECEPTOR IIB; INTERLEUKIN 10; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; SURVIVAL;

ANIMALS; ANTIGENS, CD; BONE MARROW CELLS; C-REACTIVE PROTEIN; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IGG; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037114170     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.12.7019     Document Type: Article

References (51)

1. Volanakis, J. E. 2001. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38:189.
2. Du Clos, T. W. 2000. Function of C-reactive protein. Ann. Med. 32:274.
3. Osmand, A. P., B. Friedenson, H. Gewurz, R. H. Painter, T. Hofmann, and E. Shelton. 1977. Characterization of C-reactive protein and the complement subcomponent Clt as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc. Natl. Acad. Sci. USA 74:739.
4. Volanakis, J. E., and M. H. Kaplan. 1971. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc. Soc. Exp. Biol. Med. 136:612.
5. Narkates, A. J., and J. E. Volanakis. 1982. C-reactive protein binding specificities: artificial and natural phospholipid bilayers. Ann. NY Acad. Sci. 389:172.
6. Du Clos, T. W. 1997. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Mol. Biol. Rep. 23:253.
7. Agrawal, A., and J. E. Volanakis. 1994. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis. J. Immunol. 152:5404.
8. Marnell, L. L., C. Mold, M. A. Volzer, R. W. Burlingame, and T. W. Du Clos. 1995. C-reactive protein binds to FcγRI in transfected COS cells. J. Immunol. 155:2185.
9. Galve-de Rochemonteix, B., K. Wiktorowicz, I. Kushner, and J. M. Dayer. 1993. C-reactive protein increases production of IL-1α, IL-1β, and TNF-α, and expression of mRNA by human alveolar macrophages. J. Leukocyte Biol. 53:439.
10. Ballou, S. P., and G. Lozanski. 1992. Induction of inflammatory cytokine release from human monocytes by C-reactive protein. Cytokine 4:361.
11. Yamada, Y., K. Kimball, S. Okusawa, G. Vachino, N. Margolis, S. Jeongwon, J. J. Li, G. Wakabayashi, K. McAdam, J. F. Burke, et al. 1990. Cytokines, acute phase protein, and tissue injury. Ann. NY Acad. Sci. 587:351.
12. Tilg, H., E. Vannier, G. Vachino, C. A. Dinarello, and J. W. Mier. 1993. Anti-inflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178:1629.
13. Pue, C. A., R. F. Mortensen, C. B. Marsh, H. A. Pope, and M. D. Wewers. 1996. Acute phase levels of C-reactive protein enhance IL-1β and IL-1ra production by human blood monocytes but inhibit IL-10 and IL-1ra production by alveolar macrophages. J. Immunol. 156:1594.
14. Griselli, M., J. Herbert, W. L. Hutchinson, K. M. Taylor, M. Sahail, T. Drausz, and M. B. Pepys. 1999. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J. Exp. Med. 190:1733.
15. Ahmed, N., R. Thorley, D. Y. Xia, D. Samols, and R. O. Webster. 1996. Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. Am. J. Respir. Crit. Care Med. 153:1141.
16. Zhong, S., Q. Zen, J. Tebo, K. Schlottmann, M. Coggeshall, and R. F. Mortensen. 1998. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. J. Immunol. 161:2533.
17. Xia, D., and D. Samols. 1997. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc. Natl. Acad. Sci. USA 94:2575.
18. Noursadeghi, M., M. C. Bickerstaff, J. R. Gallimore, H. J. Cohen, and M. B. Pepys. 2000. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc. Natl. Acad. Sci. USA 97:14584.
19. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Ann. Rev. Immunol. 19:275.
20. Clynes, R., J. S. Maizes, R. Guinamard, M. Ono, T. Takai, and J. V. Ravetch. 1999. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189:179.
21. Stein, M. P., C. Mold, and T. W. Du Clos. 2000. C-reactive protein binding to murine leukocytes requires Fcγ receptors. J. Immunol. 164:1514.
22. Mold, C., S. Nakayama, T. J. Holzer, H. Gewurz, and T. W. Du Clos. 1981. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J. Exp. Med. 154:1703.
23. Nakayama, S., C. Mold, H. Gewurz, and T. W. Du Clos. 1982. Opsonic properties of C-reactive protein in vivo. J. Immunol. 128:2435.
24. Szalai, A. J., J. L. VanCott, J. R. McGhee, J. E. Volanakis, and W. H. Benjamin, Jr. 2000. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice. Infect. Immun. 68:5652.
25. Xia, D., and D. Samols. 1994. Protective effect of C-reactive protein (RAB-CRP) against mediators of septic shock in transgenic mice. FASEB J. 8:A1344.
26. Bharadwaj, D., M. P. Stein, M. Volzer, C. Mold, and T. W. Du Clos. 1999. The major receptor for C-reactive protein on leukocytes is FcγRII. J. Exp. Med. 190:585.
27. Sutterwala, F. S., G. J. Noel, P. Salgame, and D. M. Mosser. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I. J. Exp. Med. 188:217.
28. Gerber, J. S., and D. M. Mosser. 2001. Reversing lipopolysaccharide toxicity by ligating the macrophage Fcγ receptors. J. Immunol. 166:6861.
29. Du Clos, T. W., L. Zlock, and L. L. Marnell. 1991. Definition of a C-reactive protein binding determinant on histones. J. Biol. Chem. 266:2167.
30. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1995. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379:346.
31. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcRγ chain deletion results in pleiotropic effector cell defects. Cell 76:519.
32. Mold. C., H. D. Gresham, and T. W. Du Clos. 2001. Serum amyloid P component (SAP) and C-reactive protein (CRP) mediate phagocytosis through murine Fcγ receptors. J. Immunol. 166:1200.
33. Chae, M. R., B. H. Park, J. S. Kim, J. W. Rho, and H. R. Kim. 2000. Protective effect of C-reactive protein against the lethality induced by Vibrio vulnificus lipopolysaccharide. Microbiol. Immunol. 44:335.
34. Bharadwaj, D., C. Mold, E. Markham, and T. W. Du Clos. 2001. Serum amyloid P component binds to Fcγ receptors and opsonizes particles for phagocytosis. J. Immunol. 166:6735.
35. Stein, M. P., J. C. Edberg, R. P. Kimberly, E. K. Mangan, D. Bharadwaj, C. Mold, and T. W. Du Clos. 2000. C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele specific. J. Clin. Invest. 105:369.
36. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495.
37. Baltz, M. L., I. F. Rowe, and M. B. Pepys. 1985. In vivo turnover studies of C-reactive protein. Clin. Exp. Immunol. 59:243.
38. Moore, K. W., R. d. W. Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
39. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
40. Reid, R., A. Prodeus, W. Khan, T. Hsu, F. S. Rosen, and M. C. Carroll. 1997. Endotoxin shock in antibody-deficient mice. J. Immunol. 159:970.
41. Fischer, M. B., A. P. Prodeus, A. Nicholson-Weller, M. Ma. J. Murrow, R. R. Reid, H. B. Warren, A. L. Lage, F. D. Moore, Jr., F. S. Rosen, and M. C. Carroll. 1997. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by Cl inhibitor replacement. J. Immunol. 159:976.
42. Libert, C., P. Brouckaert, and W. Fiers. 1994. Protection by α1-acid glycoprotein against tumor necrosis factor-induced lethality. J. Exp. Med. 180:1571.
43. Dias, A. A., A. R. Goodman, J. L. Dos Santos, R. N. Gomes, A. Altmeyer, P. T. Bozza, M. F. Horta, J. Vilcek, and L. F. Reis. 2001. TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J. Leukocyte Biol. 69:928.
44. Chi, M., A. Tridandapani, W. Zhong, K. M. Coggeshall, and R. F. Mortensen. 2002. C-reactive protein induces signaling through FcγRIIa on HL-60 granulocytes. J. Immunol. 168:1413.
45. Ioan-Facsinay, A., S. J. de Kimpe, S. M. Hellwig, P. L. van Lent, F. M. Hofhuis, H. H. van Ojik, C. Sedlik, S. A. da Silveira, J. Gerber, Y. F. de Jong, et al. 2002. FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16:391.
46. Barnes, N., A. L. Gavin, P. S. Tan, P. Mottram, F. Koentgen, and P. M. Hogarth. 2002. FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16:376.
47. Ono, M., S. Bolland, P. Tempst, and J. V. Ravetch. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 383:263.
48. Sutterwala, F. S., G. J. Noel, R. Clynes, and D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 11:1977.
49. Heuertz, R. M., C. A. Piquette, and R. O. Webster. 1993. Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am. J. Pathol. 142:319.
50. Szalai, A. J., S. Nataf, X.-Z. Hu, and S. R. Barnum. 2002. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J. Immunol. 168:5792.
51. Mold, C., B. Rodic-Polic, and T. W. Du Clos. 2002. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcγ receptors. J. Immunol. 168:6375.